Literature DB >> 17451443

Phagocytosis of Fonsecaea pedrosoi conidia, but not sclerotic cells caused by Langerhans cells, inhibits CD40 and B7-2 expression.

Jorge Pereira da Silva1, Moises Batista da Silva, Ubirajara Imbiriba Salgado, José Antonio Picanço Diniz, Sonia Rozental, Claudio Guedes Salgado.   

Abstract

Fonsecaea pedrosoi is the major etiological agent of chromoblastomycosis, a chronic, suppurative, granulomatous mycosis usually confined to skin and subcutaneous tissues, presenting a worldwide distribution. The host defense mechanisms in chromoblastomycosis have not been extensively investigated. Langerhans cells (LC) are bone-marrow-derived, dendritic antigen-presenting cells of the epidermis, which constitutively express major histocompatibility complex (MHC) class II, and comprise 1-3% of total epidermal cells. LC are localized in suprabasal layers of the epidermis and in mucosa, where they play important roles in skin immune responses. The purpose of the present study was to evaluate the interaction of F. pedrosoi conidia or sclerotic cells with LC purified from BALB/c mice skin. We demonstrate here that LC phagocytose F. pedrosoi conidia but not sclerotic cells in the first 3 h of interaction, inhibiting hyphae formation during 12-hour coculture from both forms, internalized or not. Also, LC maturation, analyzed using CD40 and B7-2 expression, was inhibited by conidia, but not by sclerotic cells, indicating an important innate immunity function of LC against F. pedrosoi infection in these mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17451443     DOI: 10.1111/j.1574-695X.2007.00239.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  9 in total

1.  Development of natural culture media for rapid induction of Fonsecaea pedrosoi sclerotic cells in vitro.

Authors:  Moises Batista da Silva; Jorge Pereira da Silva; Suellen Sirleide Pereira Yamano; Ubirajara Imbiriba Salgado; José Antonio Picanço Diniz; Claudio Guedes Salgado
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

Review 2.  Black yeasts and their filamentous relatives: principles of pathogenesis and host defense.

Authors:  Seyedmojtaba Seyedmousavi; Mihai G Netea; Johan W Mouton; Willem J G Melchers; Paul E Verweij; G Sybren de Hoog
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 3.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Fungal x host interactions in Chromoblastomycosis: what we have learned from animal models and what is yet to be solved.

Authors:  Claudio Guedes Salgado
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

Review 5.  Chromoblastomycosis.

Authors:  Paweł M Krzyściak; Małgorzata Pindycka-Piaszczyńska; Michał Piaszczyński
Journal:  Postepy Dermatol Alergol       Date:  2014-10-22       Impact factor: 1.837

6.  In situ immune response in human chromoblastomycosis--a possible role for regulatory and Th17 T cells.

Authors:  Aline Alves de Lima Silva; Paulo Ricardo Criado; Ricardo Spina Nunes; Wellington Luiz Ferreira da Silva; Luciane Kanashiro-Galo; Maria Irma Seixas Duarte; Mirian N Sotto; Carla Pagliari
Journal:  PLoS Negl Trop Dis       Date:  2014-09-18

7.  Modulation of the immune response by Fonsecaea pedrosoi morphotypes in the course of experimental chromoblastomycosis and their role on inflammatory response chronicity.

Authors:  Isaque Medeiros Siqueira; Raffael Júnio Araújo de Castro; Luiza Chaves de Miranda Leonhardt; Márcio Sousa Jerônimo; Aluízio Carlos Soares; Tainá Raiol; Christiane Nishibe; Nalvo Almeida; Aldo Henrique Tavares; Christian Hoffmann; Anamelia Lorenzetti Bocca
Journal:  PLoS Negl Trop Dis       Date:  2017-03-29

Review 8.  Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update.

Authors:  Arival Cardoso de Brito; Maraya de Jesus Semblano Bittencourt
Journal:  An Bras Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.896

Review 9.  Immune Sensing and Potential Immunotherapeutic Approaches to Control Chromoblastomycosis.

Authors:  Leandro C D Breda; Isabela G Menezes; Larissa N M Paulo; Sandro Rogério de Almeida
Journal:  J Fungi (Basel)       Date:  2020-12-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.